Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-10-017233
Filing Date
2010-02-26
Accepted
2010-02-25 19:06:35
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K g21874e10vk.htm 10-K 2334503
2 EX-10.64 g21874exv10w64.htm EX-10.64 31688
3 EX-10.65 g21874exv10w65.htm EX-10.65 12243
4 EX-21.1 g21874exv21w1.htm EX-21.1 2896
5 EX-23.1 g21874exv23w1.htm EX-23.1 3105
6 EX-31.1 g21874exv31w1.htm EX-31.1 9161
7 EX-31.2 g21874exv31w2.htm EX-31.2 9153
8 EX-32.1 g21874exv32w1.htm EX-32.1 3782
9 EX-32.2 g21874exv32w2.htm EX-32.2 3774
10 GRAPHIC g21874g2187401.gif GRAPHIC 7497
  Complete submission text file 0000950123-10-017233.txt   2422153
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15875 | Film No.: 10635564
SIC: 2834 Pharmaceutical Preparations